ESCI YOUNG INVESTIGATOR AWARD
The European Society for Clinical Investigation will award € 1,000 (+flight+hotel) + € 500 Travel Grant, to two outstanding young investigators who have made an exceptional contribution to basic/translational or clinically oriented biomedical science in Europe.
Applicants should be below the age of 45 on April 30, 2023, and from any nationality, although they must reside in Europe at the date of the application deadline (March 1, 2023).
Eligibility
The award is restricted to biomedical investigators below the age of 45 on April 30, 2023 who can be of any nationality but must reside in Europe at the date of the application/nomination deadline. ESCI may request formal evidence of this before announcing the award recipient’s name, The candidate’s work must have had a clear relevance to the understanding, diagnosis or treatment of human disease and a significant part of it must have been performed in Europe. It is the condition of the award that the recipient gives a lecture on his/her work at the 2023 Annual Scientific Meeting of ESCI, June 7-9, 2023 and submits a review article to the European Journal of Clinical Investigation summarizing the work for which the award has been given. This review should be submitted one month after the congress, before 30 June 2023.
Selection Criteria
The award recipient will be selected based on the quality of his/her publication record during the last ten years. The selection will be made by the ESCI Council, primarily focusing on the candidate’s ten most important first- or last-author primary research papers and their relevance to human disease. Priority will be given to publications describing research performed in Europe.
Instructions and deadlines
Scientists can either apply themselves for the ESCI Award or they can be nominated by an individual familiar with the candidate’s work. The completed application/nomination form along with the candidate’s CV and full publication list should be combined into a single PDF file and sent as an email attachment to esci@umcutrecht.nl no later than March 1, 2023.
Award procedure
The award will be presented during the Virtual Annual Scientific Meeting of the European Society for Clinical Investigation on June 7-9, 2023. The recipient shall give a short scientific talk of 5 min / 2 slides (directly after the award ceremony) and provide a review manuscript for publication in the European Journal of Clinical Investigation, summarizing the work for which the award has been given. The amount of 1000 Euro will be transferred to the awardee’s bank account within one week after the review manuscript has been received.
Contact Information
Please contact the ESCI Central Office at esci@umcutrecht.nl if there are any further questions or concerns.
Award Winners 2022
Young Investigator Award Clinical Research: Margherita Giannini MD, PhD
Young Investigator Award Basic Research: Marina Garcia Macia PhD, BsC
Award Winners 2021
Young Investigator Award Clinical Research: Luca Liberale, MD, FESC
Young Investigator Award Basic Research: Manuela Ferreira, PhD
Award Winners 2020
Young Investigator Award Clinical Research: Prof. Fabrizio Montecucco
Young Investigator Award Basic Research: Dr. Guadalupe Sabio
Award Winners 2019
Young Investigator Award Clinical Research: Dr. Amaia Rodriguez
Young Investigator Award Basic Research: Dr. Ruben Nogueiras
Award Winners 2018
Young Investigator Award Clinical Research: Dr. Victoria Catalán PhD BSc,
Young Investigator Award Basic Research: Dr. Miguel López, PhD
Award Winners 2017
Gemma Chiva-Blanch, PhD
Institut Català de Ciències Cardiovasculars (ICCC)
Oliver Soehnlein, MD, PhD
DZHK Professor for Vascular Immunotherapy
German Center for Cardiovascular Research (DZHK)
Institute for Cardiovascular Prevention, LMU Munich
Award Winners 2016
Prof. Marjolein van Egmond, PhD
VU University Medical Center, Amsterdam, The Netherlands
‘Monoclonal antibodies: the magic bullets to remove circulating colorectal cancel cells?”
Dr. Antoine Muchir
University of Paris, France
“Abnormal activation of mitogen activated protein kinase signaling in the pathogenesis of dilated cardiomyopathy caused by mutation in A-type lamins gene”.